Contraception
Volume 79, Issue 1 , Pages 29-34 , January 2009

Implanon® versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis — a pilot study

  • Katharina Walch

      Affiliations

    • Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna A-1090, Austria
    • ,
  • Gertrud Unfried

      Affiliations

    • Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna A-1090, Austria
    • ,
  • Johannes Huber

      Affiliations

    • Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna A-1090, Austria
    • ,
  • Christine Kurz

      Affiliations

    • Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna A-1090, Austria
    • ,
  • Michael van Trotsenburg

      Affiliations

    • Department of Obstetrics and Gynecology, Free University Amsterdam (VUmc), NL-1007 MB Amsterdam, The Netherlands
    • ,
  • Elisabeth Pernicka

      Affiliations

    • Section of Medical Statistics, Core Unit for Medical Statistics and Informatics, Medical University of Vienna, Vienna A-1090, Austria
    • ,
  • René Wenzl

      Affiliations

    • Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna A-1090, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 1 40400 2816; fax: +43 1 40400 2817.

Received 7 April 2008 ,Revised 31 July 2008 ,Accepted 31 July 2008.

References 

  1. Winkel CA. Evaluation and management of women with endometriosis. Obstet Gynecol. 2003;102:397–408
  2. Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG. Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril. 1996;65:299–304
  3. Donnez J. Today's treatments: medical, surgical and in partnership. Int J Gynaecol Obstet. 1999;64:S5–S13
  4. Aiawadi RK, Jobanputra S, Kataria M, Gurates B, Bulun SE. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril. 2004;81:290–296
  5. Ferrero S, Abbamonte LH, Anserini P, Remorgida V, Ragni N. Future perspectives in the medical treatment of endometriosis. Obstet Gynecol Surv. 2005;60:817–826
  6. Olive DL, Pritts EA. The treatment of endometriosis. Ann N Y Acad Sci. 2002;955:360–372
  7. Crosignani PG, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: an update for clinicians. Hum Reprod Update. 2006;12:179–189
  8. Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG. Depot medroxyprogesterone acetate versus oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis. Am J Obstet Gynecol. 1996;175:396–401
  9. Wenzl R, van Beek A, Schnabel P, Huber J. Pharmacogenetics of etonogestrel released from the contraceptive implant Implanon. Contraception. 1998;58:283–288
  10. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon®. Contraception. 1998;58:99S–107S
  11. The American Fertility Society . Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril. 1985;43:351–352.
  12. Vercellini P, Frontino G, De Giorgi O, Giorgio A, Zaina B, Crosignani PG. Comparison of levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril. 2003;80:305–309
  13. Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception. 1986;34:253–260
  14. Davis L, Kennedy SS, Moore J, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2007;3:CD001019
  15. Kennedy S, Bergqvist A, Chapron C, et al. on behalf of the ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20:2698–2704
  16. Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG. Progestogens for endometriosis: forward to the past. Hum Reprod Update. 2003;9:387–396
  17. Vercellini P, Pietropaolo G, De Giorgi O, Pasin R, Chiodini A, Crosignani PG. Treatment of symptomatic rectovaginal endometriosis with an estrogen–progestogen combination versus low-dose norethindrone acetate. Fertil Steril. 2005;84:1375–1387
  18. Lockhat FB, Emembolu JO, Konje JC. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod. 2005;20:789–793
  19. Zhao D, Lebovic DI, Taylor RN. Long-term progestin treatment inhibits RANTES (regulated on activation, normal T-cell expressed and secreted) gene expression in human endometrial stromal cells. J Clin Endocrinol Metab. 2002;87:2514–2519
  20. Templeman C, Boyd H, Hertweck SP. Depot medroxyprogesterone acetate use and weight gain among adolescents. J Pediatr Adolesc Gynecol. 2000;13:45–46
  21. Yisa SB, Okenwa AA, Husemeyer RB. Treatment of pelvic endometriosis with etonogestrel subdermal implant (Implanon®). J Fam Plann Reprod Health Care. 2005;31:67–70
  22. Clark MK, Dillon JS, Sowers M, Nichols S. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes. 2005;29:1252–1258
  23. Risser WI, Gefter LR, Barratt MS, Risser JMH. Weight change in adolescents who used hormonal contraception. J Adolesc Health. 1999;24:433–436
  24. London RS. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception. J SOGC. 1993;32:925–928
  25. Cagnacci A, Tirelli A, Cannoletta M, Pirillo D, Volpe A. Effect on insulin sensitivity of Implanon vs. GnRH agonist in women with endometriosis. Contraception. 2005;72:443–446
  26. Bahamondes L, Monteiro-Dantas C, Espejo-Arce X, et al. A prospective study of forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants. Hum Reprod. 2006;21:466–470
  27. Banks E, Berrington A, Casabonne D. Overview of relationship between use of progestogen-only contraceptives and bone mineral density. Br J Obstet Gynecol. 2001;108:1214–1221
  28. Beerthuizen R, van Beek A, Massai R, Mäkäräinen L, in't Hout J, Bennink HC. Bone mineral density during long-term use of the progestogen implant Implanon® compared to a non-hormonal method of contraception. Hum Reprod. 2000;15:118–122
  29. Tang OS, Tang G, Yip P, Li B, Fan S. Long-term depot-medroxyprogesterone acetate and bone mineral density. Contraception. 1999;59:25–29
  30. Kaunitz AM, Arias R, McClung M. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Contraception. 2008;77:67–76
  31. Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod. 2006;21:248–256
  32. Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril. 2006;85:314–325
  33. McCann MF, Potter LS. Progestin-only contraception: a comprehensive review. Contraception. 1994;50:S1–S195
  34. Diaz J, Faundes A, Olmos P, Diaz M. Bleeding complaints during the first year of Norplant implants use and their impact on removal rate. Contraception. 1996;53:91–95

☆ This study received an educational grant from N.V. Organon (Oss, The Netherlands). No further support was received or accepted.

PII: S0010-7824(08)00399-5

doi: 10.1016/j.contraception.2008.07.017

Contraception
Volume 79, Issue 1 , Pages 29-34 , January 2009

Article Tools

* Image Usage & Resolution